125 related articles for article (PubMed ID: 11965297)
1. Eradication of a disease: how we cured symptomless prostate cancer.
Tannock IF
Lancet; 2002 Apr; 359(9314):1341-2. PubMed ID: 11965297
[No Abstract] [Full Text] [Related]
2. Studies of prostate-cancer mortality: caution advised.
Etzioni R; Feuer E
Lancet Oncol; 2008 May; 9(5):407-9. PubMed ID: 18452850
[No Abstract] [Full Text] [Related]
3. Efficacy vs effectiveness in prostate-specific antigen screening.
Albertsen PC
J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
[No Abstract] [Full Text] [Related]
4. Prostate cancer options expand beyond the PSA.
Clin Resour Manag; 2002 May; 3(5):65-8. PubMed ID: 12048767
[No Abstract] [Full Text] [Related]
5. Clinical practice. Screening for prostate cancer.
Hoffman RM
N Engl J Med; 2011 Nov; 365(21):2013-9. PubMed ID: 22029754
[No Abstract] [Full Text] [Related]
6. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F
J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376
[TBL] [Abstract][Full Text] [Related]
7. Prostate-cancer screening.
Ojha RP; Thertulien R; Fischbach LA
N Engl J Med; 2009 Jul; 361(2):203; author reply 204-5. PubMed ID: 19593851
[No Abstract] [Full Text] [Related]
8. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
9. Stats & facts. Prostate cancer in the gender-specific scheme of things.
Manag Care Interface; 2000 Jul; 13(7):38-9. PubMed ID: 11183927
[No Abstract] [Full Text] [Related]
10. Prostate cancer in the serum prostate-specific antigen era.
Humphrey PA
Mayo Clin Proc; 1998 May; 73(5):489-90. PubMed ID: 9581595
[No Abstract] [Full Text] [Related]
11. Re: Prostate cancer incidence and mortality in the United States and the United Kingdom.
Shibata A; Whittemore AS
J Natl Cancer Inst; 2001 Jul; 93(14):1109-10. PubMed ID: 11459874
[No Abstract] [Full Text] [Related]
12. International comparisons of cumulative risk of breast and prostate cancer, from cancer incidence in five continents Vol. VIII.
Marugame T; Katanoda K
Jpn J Clin Oncol; 2006 Jun; 36(6):399-400. PubMed ID: 16818481
[No Abstract] [Full Text] [Related]
13. Observed effect of age and body mass index on total and complexed PSA: analysis from a National Screening Program.
Walsh PC
J Urol; 2005 Nov; 174(5):1825-6. PubMed ID: 16217298
[No Abstract] [Full Text] [Related]
14. Screening for adenocarcinoma of the prostate.
Elias PH
Mayo Clin Proc; 2006 Jan; 81(1):132; author reply 132-3. PubMed ID: 16438491
[No Abstract] [Full Text] [Related]
15. [Detection of prostate cancer: yes or no?].
Van Cangh PJ
Bull Mem Acad R Med Belg; 2006; 161(3-4):159-69. PubMed ID: 17172224
[No Abstract] [Full Text] [Related]
16. Prostate cancer incidence and mortality in the United States and the United Kingdom.
Shibata A; Ma J; Whittemore AS
J Natl Cancer Inst; 1998 Aug; 90(16):1230-1. PubMed ID: 9719085
[No Abstract] [Full Text] [Related]
17. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.
Colli JL; Amling CL
Prostate Cancer Prostatic Dis; 2008; 11(3):247-51. PubMed ID: 18268527
[TBL] [Abstract][Full Text] [Related]
18. Screening for prostate cancer - will we ever know?
Adolfsson J
Acta Oncol; 2010 Apr; 49(3):275-7. PubMed ID: 20397764
[No Abstract] [Full Text] [Related]
19. Balancing the harms and benefits of early detection of prostate cancer.
van Leeuwen PJ; Connolly D; Tammela TL; Auvinen A; Kranse R; Roobol MJ; Schroder FH; Gavin A
Cancer; 2010 Oct; 116(20):4857-65. PubMed ID: 20839233
[TBL] [Abstract][Full Text] [Related]
20. Regular PSA screens undervalued, underutilized in prostate cancer detection.
Healthc Demand Dis Manag; 2000 May; 6(5):70-2, 65. PubMed ID: 11383016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
